Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer
06:30 EDT 5 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Agios Pharmaceuticals, the leading biopharmaceutical company focused on
discovering and developing novel drugs in cancer metabolism, announced
today the publication of a new study that provides further evidence of
the link betwe...
Other Sources for this Article
Agios Pharmaceuticals
Dan Budwick, 973-271-6085
dan@purecommunicationsinc.com
More From BioPortfolio on "Nature Publication from Agios Scientists and Co-founder Reinforces Link Between Key Metabolic Enzyme IDH and Cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
